Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's Laboratories

This page shows the latest Dr Reddy's Laboratories news and features for those working in and with pharma, biotech and healthcare.

Indivior slumps as patent dispute rises US generic spectre

Indivior slumps as patent dispute rises US generic spectre

Indivior said it plans to appeal the decision, which held that three US patents on Suboxone were valid but that a generic from Indian drugmaker Dr Reddy's Laboratories drug does ... He said that Dr Reddy's has not yet been granted FDA approval for its

Latest news

  • Fresenius Kabi buys Akorn and Merck's biosimilar businesses Fresenius Kabi buys Akorn and Merck's biosimilar businesses

    Adding in Merck's biosimilars business takes it right back into the biotech sphere. ... Merck kicked off its biosimilar programme in 2012 via an agreement with India's Dr Reddy's Laboratories at a time when the company was facing patent expiries on some

  • Merck confirms sale of biosimilar division Merck confirms sale of biosimilar division

    The German group kicked off its biosimilar programme in 2012 via an agreement with India's Dr Reddy's Laboratories, at a time when the company was facing patent expiries on ... At the time the Dr Reddy's deal was announced the biosimilars market was a

  • Dr Reddy's brings its generics portfolio to France Dr Reddy's brings its generics portfolio to France

    Dr Reddy's brings its generics portfolio to France. Continues the European roll-out of its oncology and anti-infective products. ... Dr Reddy's Laboratories will next month launch its generics portfolio in France as it continues to expand its European

  • Dr. Reddy’s enters €118m product agreement with UCB in India Dr. Reddys enters €118m product agreement with UCB in India

    Dr. Reddy’ s enters 118m product agreement with UCB in India. ... Portfolio acquisition will expand firm’ s therapy footprint. Dr. Reddy's Laboratories has entered a 118m (INR 800 Crores) definitive agreement to acquire a select portfolio of

  • Global biosimilars market “will see exponential growth” Global biosimilars market “will see exponential growth”

    Already, Indian groups such as Dr Reddy's Laboratories, Biocon and Reliance Life Sciences are making a concerted effort to enter the European market,” says F&S, although it indicates that ... infliximab), which was approved in the indications

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    The three deals with Mayne Pharma, Impax Laboratories and Dr Reddy's, for a combined value of over $1.5bn, cover portfolios of marketed and approved generic drugs, drugs currently pending ... acquisition assets/ return of rights. 586. Teva and Allergan/

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • MedImmune appoints Dr Anand Subramony MedImmune appoints Dr Anand Subramony

    While at Novartis Dr Subramony established and headed company's novel delivery technologies and therapeutics group. ... Prior to that he held leadership positions at Dr. Reddy's Laboratories in Bridgewater, New Jersey and Johnson &Johnson/Alza

  • New global head of HR for Dr Reddy’s New global head of HR for Dr Reddys

    New global head of HR for Dr Reddy’ s. Sripada Chandrasekhar joins from IBM. ... Hyderabad, India-headquartered Dr Reddy's Laboratories has appointed a former IBM executive president and global head of human resources.

  • Dr Reddy’s appoints Umang Vohra to lead US business Dr Reddys appoints Umang Vohra to lead US business

    Dr Reddy’ s appoints Umang Vohra to lead US business. Will be replaced as chief financial officer by Saumen Chakraborty. ... Indian generics company Dr Reddy's Laboratories has appointed Umang Vohra as the new head of its North American business.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics